RMR Wealth Builders Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

RMR Wealth Builders decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 72.8% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,097 shares of the healthcare conglomerate's stock after selling 2,937 shares during the quarter. RMR Wealth Builders' holdings in UnitedHealth Group were worth $574,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group in the fourth quarter valued at $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. TD Securities reaffirmed a "hold" rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. KeyCorp lowered their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research note on Monday, June 2nd. Deutsche Bank Aktiengesellschaft cut their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. Finally, Oppenheimer dropped their price target on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $426.52.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer now owns 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have purchased 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Trading Down 1.6%

Shares of UNH stock traded down $5.11 during mid-day trading on Friday, reaching $313.39. 13,729,200 shares of the stock traded hands, compared to its average volume of 7,185,786. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a market cap of $284.28 billion, a price-to-earnings ratio of 20.22, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45. The stock's fifty day simple moving average is $386.66 and its two-hundred day simple moving average is $474.19.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.82%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.